George J. Morrow is on the board of Neurocrine Biosciences, Inc. and Align Technology, Inc.

Mr. Morrow previously was Executive VP-Global Commercial Operations at Amgen, Inc., Vice President-Marketing for Merck & Co., Inc. and President, Chief Executive Officer & Director at Glaxo Wellcome, Inc.

He received a graduate degree from Bryn Mawr College, an MBA from The Fuqua School of Business, an undergraduate degree from Southampton City College and an undergraduate degree from Long Island University.